NovaBay Pharmaceuticals, Inc. (NBY)
Total Valuation
NBY has a market cap or net worth of $3.35 million. The enterprise value is $2.96 million.
Market Cap | 3.35M |
Enterprise Value | 2.96M |
Important Dates
The last earnings date was Tuesday, March 26, 2024, after market close.
Earnings Date | Mar 26, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
NBY has 30.10 million shares outstanding. The number of shares has increased by 161.80% in one year.
Shares Outstanding | 30.10M |
Shares Change (YoY) | +161.80% |
Shares Change (QoQ) | -10.17% |
Owned by Insiders (%) | 2.44% |
Owned by Institutions (%) | 18.21% |
Float | 29.81M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.23 |
Forward PS | 0.22 |
PB Ratio | 1.01 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.20 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.83.
Current Ratio | 1.67 |
Quick Ratio | 0.91 |
Debt / Equity | 0.83 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -240.20% and return on invested capital (ROIC) is -125.47%.
Return on Equity (ROE) | -240.20% |
Return on Assets (ROA) | -126.70% |
Return on Capital (ROIC) | -125.47% |
Revenue Per Employee | $507,793 |
Profits Per Employee | -$575,759 |
Employee Count | 29 |
Asset Turnover | 1.12 |
Inventory Turnover | 2.16 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.26% in the last 52 weeks. The beta is 2.00, so NBY's price volatility has been higher than the market average.
Beta (1Y) | 2.00 |
52-Week Price Change | -93.26% |
50-Day Moving Average | 0.15 |
200-Day Moving Average | 0.40 |
Relative Strength Index (RSI) | 32.02 |
Average Volume (30 Days) | 3,525,939 |
Short Selling Information
The latest short interest is 271,720, so 0.90% of the outstanding shares have been sold short.
Short Interest | 271,720 |
Short Previous Month | 576,563 |
Short % of Shares Out | 0.90% |
Short % of Float | 0.91% |
Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, NBY had revenue of $14.73 million and -$16.70 million in losses. Loss per share was -$3.96.
Revenue | 14.73M |
Gross Profit | 7.90M |
Operating Income | -7.60M |
Pretax Income | -9.64M |
Net Income | -16.70M |
EBITDA | -9.44M |
EBIT | -9.64M |
Loss Per Share | -$3.96 |
Balance Sheet
The company has $3.13 million in cash and $2.74 million in debt, giving a net cash position of $390,000 or $0.01 per share.
Cash & Cash Equivalents | 3.13M |
Total Debt | 2.74M |
Net Cash | 390,000 |
Net Cash Per Share | $0.01 |
Equity / Book Value | 3.31M |
Book Value Per Share | 0.11 |
Working Capital | 2.88M |
Cash Flow
In the last 12 months, operating cash flow was -$4.13 million and capital expenditures -$19,000, giving a free cash flow of -$4.15 million.
Operating Cash Flow | -4.13M |
Capital Expenditures | -19,000 |
Free Cash Flow | -4.15M |
FCF Per Share | -$0.99 |
Margins
Gross margin is 53.61%, with operating and profit margins of -51.58% and -113.38%.
Gross Margin | 53.61% |
Operating Margin | -51.58% |
Pretax Margin | -65.46% |
Profit Margin | -113.38% |
EBITDA Margin | -64.08% |
EBIT Margin | -65.46% |
FCF Margin | -28.18% |
Dividends & Yields
NBY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -161.80% |
Shareholder Yield | -161.80% |
Earnings Yield | -498.88% |
FCF Yield | -123.99% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 16, 2022. It was a reverse split with a ratio of 1:35.
Last Split Date | Nov 16, 2022 |
Split Type | Reverse |
Split Ratio | 1:35 |
Scores
NBY has an Altman Z-Score of -28.25 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -28.25 |
Piotroski F-Score | 3 |